Abaigeal D. Jackson, Christopher H. Goss  Journal of Cystic Fibrosis 

Slides:



Advertisements
Similar presentations
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
Advertisements

Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Cystic Fibrosis Foundation and European Cystic Fibrosis Society Survey of cystic fibrosis mental health care delivery  J. Abbott, J.S. Elborn, A.M. Georgiopoulos,
P. Whitaker, N. Shaw, J. Gooi, C. Etherington, S. Conway, D. Peckham 
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Cirrhosis and other liver disease in cystic fibrosis
Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin 
David N. Sheppard  Journal of Cystic Fibrosis 
John Widger, Sarath Ranganathan, Philip J. Robinson 
Rate of improvement of CF life expectancy exceeds that of general population— Observational death registration study  Matthew N. Hurley, Tricia M. McKeever,
Pulmonary exacerbations in CF patients with early lung disease
The application of current lifetable methods to compare cystic fibrosis median survival internationally is limited  Abaigeal D. Jackson, Leslie Daly,
Controlled clinical trials in cystic fibrosis — are we doing better?
Feasibility of using pedometers to measure daily step counts in cystic fibrosis and an assessment of its responsiveness to changes in health state  Bradley.
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Cystic fibrosis mortality trend in Italy from 1970 to 2011
Influence of digital clubbing on oxygen saturation measurements by pulse-oximetry in cystic fibrosis patients  Filip Van Ginderdeuren, Karlien Van Cauwelaert,
Vitamin A and lung function in CF
A.H. Gifford  Journal of Cystic Fibrosis 
M. Wouthuyzen-Bakker, F.A.J.A. Bodewes, H.J. Verkade 
Demographics of glucose metabolism in cystic fibrosis
Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009  Yolanda P. Lillquist,
M. Al-Aloul, M. Jackson, G. Bell, M. Ledson, M. Walshaw 
Cystic fibrosis related diabetes in an extremely young patient
Inhalation solutions — Which ones may be mixed
Antonia V. Bennett, Donald L. Patrick, James F. Lymp, Todd C
Elisabeth P. Dellon, Elaine Chen, Jessica Goggin, Karen Homa, Bruce C
Characterisation of mutations and genotype–phenotype correlation in cystic fibrosis: Experience from India  Shivaram S. Shastri, Madhulika Kabra, Sushil.
Sophia L. Markantonis, Anna Katelari, Eleni Pappa, Stavros Doudounakis 
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
Sally H. Pattison, Geraint B. Rogers, Martin Crockard, J
Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis  Christopher R. Sudfeld, Elliott C. Dasenbrook, William.
Stenotrophomonas maltophilia in cystic fibrosis: Improved detection by the use of selective agar and evaluation of antimicrobial resistance  P. Goncalves-Vidigal,
Nasal polyposis in lung transplant recipients with cystic fibrosis
Elliott C. Dasenbrook, Gregory S. Sawicki  Journal of Cystic Fibrosis 
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United.
Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention  H. White, K. Pollard, C. Etherington, I. Clifton,
Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire  Joän M. Patterson, Melanie Wall, Jerica.
Michael D. Parkins, R. Andres Floto  Journal of Cystic Fibrosis 
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal 
Diabetes mellitus and survival in cystic fibrosis patients after lung transplantation  Markus Hofer, Christoph Schmid, Christian Benden, Rudolf Speich,
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
H. White, A.M. Morton, S.P. Conway, D.G. Peckham 
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid 
D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher 
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
L. Nshimyumukiza, A. Bois, P. Daigneault, L. Lands, A. -M. Laberge, D
Beta-lactam allergy in adults with cystic fibrosis
Predictors of non-referral of patients with cystic fibrosisfor lung transplant evaluation in the United States  Kathleen J. Ramos, Bradley S. Quon, Kevin.
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern? 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Improved early diagnosis of Pseudomonas aeruginosa by real-time PCR to prevent chronic colonisation in a paediatric cystic fibrosis population  Elaine.
Absence of a gender gap in survival
Respiratory physicians and clinic coordinators' attitudes to population-based cystic fibrosis carrier screening  Fiona Cunningham, Sharon Lewis, Lisette.
Presentation transcript:

Epidemiology of CF: How registries can be used to advance our understanding of the CF population  Abaigeal D. Jackson, Christopher H. Goss  Journal of Cystic Fibrosis  Volume 17, Issue 3, Pages 297-305 (May 2018) DOI: 10.1016/j.jcf.2017.11.013 Copyright © 2017 European Cystic Fibrosis Society Terms and Conditions

Fig. 1 Countries with a cystic fibrosis registry, reproduced with permission of the US Cystic Fibrosis Foundation, Bethesda Maryland. Journal of Cystic Fibrosis 2018 17, 297-305DOI: (10.1016/j.jcf.2017.11.013) Copyright © 2017 European Cystic Fibrosis Society Terms and Conditions

Supplementary Fig. S1 Summary of 2015 CFFPR and 2015 ECFSPR annual registry data reports, reproduced with permission of the US Cystic Fibrosis Foundation, Bethesda, Maryland and the European Cystic Fibrosis Society Patient Registry, Karup, Denmark. Journal of Cystic Fibrosis 2018 17, 297-305DOI: (10.1016/j.jcf.2017.11.013) Copyright © 2017 European Cystic Fibrosis Society Terms and Conditions

Supplementary Fig. S1 Summary of 2015 CFFPR and 2015 ECFSPR annual registry data reports, reproduced with permission of the US Cystic Fibrosis Foundation, Bethesda, Maryland and the European Cystic Fibrosis Society Patient Registry, Karup, Denmark. Journal of Cystic Fibrosis 2018 17, 297-305DOI: (10.1016/j.jcf.2017.11.013) Copyright © 2017 European Cystic Fibrosis Society Terms and Conditions

Supplementary Fig. S1 Summary of 2015 CFFPR and 2015 ECFSPR annual registry data reports, reproduced with permission of the US Cystic Fibrosis Foundation, Bethesda, Maryland and the European Cystic Fibrosis Society Patient Registry, Karup, Denmark. Journal of Cystic Fibrosis 2018 17, 297-305DOI: (10.1016/j.jcf.2017.11.013) Copyright © 2017 European Cystic Fibrosis Society Terms and Conditions